## RUN: Sunrun Inc. - XLK: Technology

### Executive Summary

VALUE thesis: PEG 0.45 indicates fundamental undervaluation. Consistent execution (3/4 quarters beat estimates). Caution: momentum weakening (-4.3% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($14.80)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 2
- **Sentiment:** Bearish (Bullish: 0, Bearish: 2)

**1. 3 Reasons RUN is Risky and 1 Stock to Buy Instead**
- Source: Finviz | 20251205T102400 | Bearish | Relevance: 100%
- This article outlines three reasons why Sunrun (RUN) is considered a risky investment despite a recent surge in its stock price. These reasons include flatlining revenue growth, a significant cash burn rate, and a short cash runway coupled with high debt that could lead to dilution for shareholders. The author suggests looking for alternative investments due to Sunrun's foundational issues and advises caution until the company demonstrates consistent free cash flow.

**2. Why Sunrun (RUN) Shares Are Sliding Today**
- Source: Finviz | 20251203T114700 | Bearish | Relevance: 95%
- Sunrun (NASDAQ:RUN) shares fell 2.5% after a director sold a significant number of shares, raising investor concerns about the company's near-term outlook. Broad industry concerns about rising prices for essential solar module components also contributed to the negative sentiment, potentially squeezing profit margins for solar companies. Despite a strong performance earlier in the year, these factors led to a decline in stock value.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-02 | Morgan Stanley | $21 | $20 | +5% |
| 2025-11-11 | Wells Fargo | $21 | $14 | +50% |
| 2025-11-10 | Guggenheim | $27 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-02 | Morgan Stanley | main | Equal-Weight |
| 2025-11-11 | Wells Fargo | main | Overweight |
| 2025-11-10 | Guggenheim | up | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 3 ($0.01M) |
| Sells | 19 ($7.13M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 55.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Blackrock Inc.: 16.1% (+0.2%)
- Vanguard Group Inc: 10.4% (+1.2%)
- Greenvale Capital, L: 5.8% (-2.1%)
- Shaw D.E. & Co., Inc: 4.1% (+533.8%)
- State Street Corpora: 4.0% (-0.9%)

### Key Risks

1. High beta (2.35) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Momentum deterioration: MRS_20 falling (-4.3% 5d) with bearish MACD, trend may be turning.
3. Insider selling cluster: $7.1M in recent transactions.
4. High short interest (31.1%, 8.4 days to cover): squeeze risk or crowded bearish bet.
5. Near-term weakness: 8.7% below SMA50 despite long-term uptrend.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.45 indicates undervaluation relative to growth. Analyst sentiment positive (2 raises, avg +28%). Insider selling cluster ($7.1M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $4.7B |
| Beta | 2.35 |
| 52W Range | $5.38 - $22.44 |
| Short Interest | 31.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.45 |
| Forward P/E | 22.9 |
| Current P/E | 12.9 |
| YoY Growth | -43.6% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from -3.2% to -7.5% (-4.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 11.5pp (needs >4.0% for momentum thesis). AM_20 at -5.3% indicates price below own 20MA trend. Underperforming sector by 7.8pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.44x) but short-term weakness (below SMA20). RSI neutral at 44. OFD pattern: -MTL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -7.49% (CS: 4) | Weak |
| RSI_14 | 43.6 | Neutral |
| MACD Histogram | -0.11 | Bearish |
| vs SMA20 | 0.947x | Below |
| vs SMA50 | 0.913x | Below |
| vs SMA200 | 1.440x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $17.58
- **Stop Loss:** $14.80 (15.8% risk)
- **Target:** $23.14 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 359
- **Position Value:** $6,311.22
- **Portfolio %:** 6.31%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-02-26 (Est: $-0.07)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.12 | $0.06 | -48.7% |
| 2025Q2 | $-0.12 | $1.07 | +1030.4% |
| 2025Q1 | $-0.27 | $0.20 | +173.5% |
| 2024Q4 | $-0.19 | $1.41 | +837.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*